Wendy Broom

Wendy Broom is a seasoned professional in oncology research, currently serving as Senior Director at Alnylam Pharmaceuticals since December 2021, where efforts focus on leveraging RNA interference to develop oncology therapies. Previously, in roles at Codiak BioSciences and Genocea Biosciences, Wendy directed oncology initiatives aimed at innovative drug delivery and personalized cancer vaccines, respectively. An extensive background includes significant contributions at Novartis Institutes for BioMedical Research, driving multidisciplinary projects across diverse therapeutic areas, and early research in neurology at Massachusetts General Hospital/Harvard Medical School. Wendy Broom holds a Ph.D. in Molecular Biology and Genetics from King's College London and a B.Sc. in Biochemistry from the University of Bath.